Month: April 2026

HAMPTON, N.H., April 21, 2026 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its first quarter 2026 earnings after the market closes on May 4, 2026. Unitil will host its conference call and webcast on May 5, 2026 at 2:00 p.m. (ET) to review its quarterly results. Related presentation materials will be available before the call on the Company’s Investors page at investors.unitil.com. The conference call will be broadcast live in listen-only mode on the Company’s Investors page at investors.unitil.com. Interested parties may access dial information for the call by registering via web link here. An archive of the webcast will be available for one year on the website at investors.unitil.com. About Unitil Corporation Unitil Corporation provides energy for life by safely and reliably delivering...

MAINZ, Germany, April 21, 2026 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. ET (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this link. Participants may also access the slides and the webcast of the conference call via the “Events & Presentations” page in the Investor...

KALMAR CORPORATION, PRESS RELEASE, 21 APRIL 2026 AT 13:35 (EEST)  Kalmar’s January–March 2026 interim report to be published on Tuesday, 5 May 2026 Kalmar Corporation will publish its January–March 2026 interim report on 5 May 2026 at approximately 9:00 a.m. EEST. The report will be available at https://www.kalmarglobal.com/investors/ after publication. A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 10:00 a.m. EEST. The event will be held in English. The report will be presented by President & CEO Sami Niiranen and CFO Sakari Ahdekivi. The presentation material will be available at https://www.kalmarglobal.com/investors by the latest 10:00 a.m. EEST. To ask questions, please join the teleconference by registering via the following link: https://events.inderes.com/kalmar/q1-2026/dial-in....

Net sales were $23 million in the second quarter, with gross profit of $7 million and gross margin1 reaching 30.6%, a 12.0 percentage points decline over the Q2 last year Net loss of $7 million compared to $2 million in the same period last year, adjusted EBITDA margin2 of negative 4.4% and adjusted EBITDA2 loss of $1 million for the second quarter Cash flows used by operating activities of $2.4 million and adjusted free cash flow2 was negative $2.0 million for the second quarter, with cash balance and marketable securities3 at $9 million bringing net leverage2 ratio to 10x Advancing a focused strategic reset centered on an enhanced product offering and a disciplined cost structure to drive sustainable, profitable growthMONTREAL, April 21, 2026 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood”, “the Company”, “us”, “we”...

VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada. Expansion Roadmap The Company has published “The Path Forward,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation is now available on the Company’s website at avricore.com/investor-kit. The update outlines Avricore’s progression from NHS-linked pilot programmes...

 Kering – Press Release – Changes in the membership of the Board of Directors – 2026 04 21PRESS RELEASEApril 21, 2026CHANGES IN THE MEMBERSHIP OF THE BOARD OF DIRECTORS OF KERING The Board of Directors of Kering, on the recommendation of the Appointments and Governance Committee, will propose the appointment of two independent directors at the Annual General Meeting on May 28, 2026: Marie-Hélène Chenut and Laurent Kleitman.Marie-Hélène Chenut, a French national, held operational and strategic responsibilities at Chanel for over 35 years, with an international scope in marketing, business development, and talent development, before leading the Haute Couture division and the Haute Couture and Ready-to-Wear ateliers for nine years. Her industry expertise, understanding of business, operational and brand-related...

Neinor Homes announces an orderly leadership transition with the appointment of Jordi Argemí as CEO from 2027Borja García-Egotxeaga will step down as CEO at the end of 2026 and will remain linked to the company as Senior Advisor following the transition period Jordi Argemí, current Deputy CEO and CFO, has been responsible for the company’s growth and success in recent years, ensuring full strategic continuity Additionally, it has been agreed to appoint Jordi Argemí as Co-CEO and will assume the role of CEO from 1 January 2027 Neinor has consolidated its position as Spain’s leading residential platform and enters this new phase from a position of strength to continue growing under its equity efficient strategyMadrid, 21 April 2026 – The Board of Directors of Neinor Homes (“Neinor”) has today approved an orderly succession plan under...